HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy

Iron accumulation causes cell death and disrupts tissue functions, which necessitates chelation therapy to reduce iron overload. However, clinical utilization of deferoxamine (DFO), an iron chelator, has been documented to give rise to systemic adverse effects, including ocular toxicity. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Yang, Liu, Pei‐Kang, Li, Yao, Nolan, Nicholas D, Quinn, Peter M J, Hsu, Chun‐Wei, Jenny, Laura A, Zhao, Jin, Cui, Xuan, Chang, Ya‐Ju, Wert, Katherine J, Sparrow, Janet R, Wang, Nan‐Kai, Tsang, Stephen H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906391/
https://www.ncbi.nlm.nih.gov/pubmed/36645044
http://dx.doi.org/10.15252/emmm.202216525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906391/
https://www.ncbi.nlm.nih.gov/pubmed/36645044
http://dx.doi.org/10.15252/emmm.202216525

Ejemplares similares